THEMISMED · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Themis Medicare has informed the stock exchanges that its Board of Directors will meet on Friday, 1st August 2025 to consider and approve the unaudited standalone and consolidated financial results for the quarter ended 30th June 2025, along with the auditor's limited review report. The company has also confirmed that the trading window for designated persons remains closed from 1st July 2025 until 48 hours after the results are published, in line with insider trading regulations. This is a routine procedural filing under SEBI Listing Regulations. No financial numbers or outcomes have been disclosed yet.
No immediate impact on shareholders — this is a pre-results announcement. Investors should watch for the actual Q1 FY26 numbers on 1st August 2025 for any meaningful insight into the company's performance and outlook.